Tae Hoon Lee, MD, PhD
@lthoon0420.bsky.social
Radiation Oncologist / Clinical Assistant Professor in Samsung Medical Center / The Korean Society for Radiation Oncology / Breast, prostate, and skin cancer / https://orcid.org/0000-0002-4723-3931
AI auto-contouring software in my department recently got an update, and I feel that it’s getting more usable even for certain CTVs. Some of the ROs I met in FARO 2025 also said that they are conducting much less manual contouring. (Some opposed that statement, though.)
November 16, 2025 at 8:57 AM
AI auto-contouring software in my department recently got an update, and I feel that it’s getting more usable even for certain CTVs. Some of the ROs I met in FARO 2025 also said that they are conducting much less manual contouring. (Some opposed that statement, though.)
Today is my last day in Chiang Mai. FARO 2025 inspired me greatly through diversity and cooperation. See you in Singapore for ESTRO Meets Asia in 2026! #FARO2025
November 15, 2025 at 7:07 AM
Today is my last day in Chiang Mai. FARO 2025 inspired me greatly through diversity and cooperation. See you in Singapore for ESTRO Meets Asia in 2026! #FARO2025
I am truly proud to see Dr. Hong-Gyun Wu, former president of the Korean Society, presenting at FARO 2025 as president-elect of FARO. He was my mentor when I was trained at Seoul National University Hospital. #FARO2025
November 14, 2025 at 5:41 AM
I am truly proud to see Dr. Hong-Gyun Wu, former president of the Korean Society, presenting at FARO 2025 as president-elect of FARO. He was my mentor when I was trained at Seoul National University Hospital. #FARO2025
I'm at FARO 2025 in Chiang Mai, Thailand. Dr. Vedang Murthy gave a great lecture on RT for bladder cancer, emphasizing the effectiveness of RT. Indeed, he has made great accomplishments. I consider him one of the greatest Asian GU RadOnc of our time. #FARO2025
November 14, 2025 at 5:41 AM
I'm at FARO 2025 in Chiang Mai, Thailand. Dr. Vedang Murthy gave a great lecture on RT for bladder cancer, emphasizing the effectiveness of RT. Indeed, he has made great accomplishments. I consider him one of the greatest Asian GU RadOnc of our time. #FARO2025
31th anniversary of Samsung Medical Center!
November 7, 2025 at 7:53 AM
31th anniversary of Samsung Medical Center!
So, Cureus got delisted from Web of Science. Unfortunate for them. retractionwatch.com/2025/10/27/e...
Embattled journal Cureus delisted from Web of Science, loses impact factor
Clarivate has removed the mega-journal Cureus from its Master Journal List, according to the October update, released today. The move means Cureus will no longer be indexed in Web of Science …
retractionwatch.com
October 29, 2025 at 2:11 AM
So, Cureus got delisted from Web of Science. Unfortunate for them. retractionwatch.com/2025/10/27/e...
Recently I got interested in applying intraprostatic focal boost for prostate SBRT and we have a new trial from UK just got online in IJROBP doi.org/10.1016/j.ij...
Redirecting
doi.org
October 28, 2025 at 1:00 AM
Recently I got interested in applying intraprostatic focal boost for prostate SBRT and we have a new trial from UK just got online in IJROBP doi.org/10.1016/j.ij...
This year's KOSRO Conference featured a seminar on ultra-hypofractionated RT, with JS Chang discussing breast cancer, H Nagar presenting on prostate cancer, and R Timmerman speaking about PULSAR.
October 17, 2025 at 8:07 AM
This year's KOSRO Conference featured a seminar on ultra-hypofractionated RT, with JS Chang discussing breast cancer, H Nagar presenting on prostate cancer, and R Timmerman speaking about PULSAR.
Twoarc trial compared 50.4 Gy in 28 fxs vs. 33 Gy in 10 fxs in neoadjuvant CCRT for rectal cancer. This trial is recently published in Annals of Surgery #RectalCancer
October 17, 2025 at 12:49 AM
Twoarc trial compared 50.4 Gy in 28 fxs vs. 33 Gy in 10 fxs in neoadjuvant CCRT for rectal cancer. This trial is recently published in Annals of Surgery #RectalCancer
SHARE trial compared 66 Gy in 33 fxs vs. 65 Gy in 26 fxs for salvage RT for biochemical recurrence after prostatectomy. The cohort has not yet matured for the primary outcome. Moderate hypoRT with 65 Gy was associated with increased GI toxicity. #ProstateCaner
October 17, 2025 at 12:18 AM
SHARE trial compared 66 Gy in 33 fxs vs. 65 Gy in 26 fxs for salvage RT for biochemical recurrence after prostatectomy. The cohort has not yet matured for the primary outcome. Moderate hypoRT with 65 Gy was associated with increased GI toxicity. #ProstateCaner
Jeong Ha Lee, a resident physician of RO department of Samsung Medical Center, made a presentation for proton beam therapy as a local ablative therapy in pancreatic cancer. Congrats!
October 16, 2025 at 11:55 PM
Jeong Ha Lee, a resident physician of RO department of Samsung Medical Center, made a presentation for proton beam therapy as a local ablative therapy in pancreatic cancer. Congrats!
We are ready for The Korean Society of Radiation Oncology Annual Conference!
October 16, 2025 at 11:03 PM
We are ready for The Korean Society of Radiation Oncology Annual Conference!
Excited to share that my co-authored article on low-level laser therapy for reducing severe radiation-induced oral mucositis is now published online. I contributed to this work through our department's Quality of Life team. doi.org/10.1002/lsm....
Feasibility Study of a Novel Stent‐Based Low‐Level Laser Therapy Device for Reducing Severe Radiation‐Induced Oral Mucositis
Objectives
Radiation-induced oral mucositis (RIOM) is a severe complication of radiotherapy (RT) for head and neck cancers, impairing quality of life and treatment adherence. Low-level laser therapy.....
doi.org
October 11, 2025 at 7:33 AM
Excited to share that my co-authored article on low-level laser therapy for reducing severe radiation-induced oral mucositis is now published online. I contributed to this work through our department's Quality of Life team. doi.org/10.1002/lsm....
Reposted by Tae Hoon Lee, MD, PhD
A phase 2 trial demonstrated an isotoxic improvement in #cancer control with prostate-specific membrane antigen positron emission tomography-guided intensification of salvage RT after radical prostatectomy.
ja.ma/48tWkkb
ja.ma/48tWkkb
October 2, 2025 at 3:15 PM
A phase 2 trial demonstrated an isotoxic improvement in #cancer control with prostate-specific membrane antigen positron emission tomography-guided intensification of salvage RT after radical prostatectomy.
ja.ma/48tWkkb
ja.ma/48tWkkb
Reposted by Tae Hoon Lee, MD, PhD
Rockstar #radonc @mskcancercenter.bsky.social resident Dr Kaitlyn Lapen presents at #ASTRO25 on quality of life improvements with early radiation for asymptomatic bone metastasis which may appear after 6 months. Optimal patient selection is key. @astro-org.bsky.social
September 29, 2025 at 6:20 PM
Rockstar #radonc @mskcancercenter.bsky.social resident Dr Kaitlyn Lapen presents at #ASTRO25 on quality of life improvements with early radiation for asymptomatic bone metastasis which may appear after 6 months. Optimal patient selection is key. @astro-org.bsky.social
Dr. Cheng reported 30Gy/26Gy/5fx SIB tumor bed boost for whole breast irradiation on behave of her colleagues in Beijing. I have a few words for this. #ASTRO25
September 30, 2025 at 3:55 PM
Dr. Cheng reported 30Gy/26Gy/5fx SIB tumor bed boost for whole breast irradiation on behave of her colleagues in Beijing. I have a few words for this. #ASTRO25
Primary outcomes of NRG GU005 study will be presented soon in the plenary session, though for the secondary outcomes there are some discrepancies between already-published studies for prostate cancer SBRT. I wonder why… #ASTRO25
September 29, 2025 at 6:50 PM
Primary outcomes of NRG GU005 study will be presented soon in the plenary session, though for the secondary outcomes there are some discrepancies between already-published studies for prostate cancer SBRT. I wonder why… #ASTRO25
Dr. Sang Hoon Seo, a resident physician of Samsung Medical Center Department of Radiation Oncology, presented blood dosimetry models in craniospinal irradiation, suggesting that blood DVH D5% can be a predictor of worse survival. Great job! #ASTRO25
September 28, 2025 at 10:46 PM
Dr. Sang Hoon Seo, a resident physician of Samsung Medical Center Department of Radiation Oncology, presented blood dosimetry models in craniospinal irradiation, suggesting that blood DVH D5% can be a predictor of worse survival. Great job! #ASTRO25
LoRD-KNeA trial observed efficacy of low-dose RT in knee arthritis. 4-month response rates were 58.3% (0.3 Gy) vs. 70.3 (3 Gy) vs. 41.7% (0 Gy, sham), provides objective evidence for the efficacy of low-dose RT. Really proud of prof. Byoung Hyuk Kim! #ASTRO25
September 28, 2025 at 9:20 PM
LoRD-KNeA trial observed efficacy of low-dose RT in knee arthritis. 4-month response rates were 58.3% (0.3 Gy) vs. 70.3 (3 Gy) vs. 41.7% (0 Gy, sham), provides objective evidence for the efficacy of low-dose RT. Really proud of prof. Byoung Hyuk Kim! #ASTRO25
I’ve checked out this year’s posters from Sang Hoon Seo, who is currently a resident physician in my institution. He will make an oral presentation for another abstract in the CNS section today. Very enthusiastic, isn’t he? #ASTRO25
September 28, 2025 at 6:17 PM
I’ve checked out this year’s posters from Sang Hoon Seo, who is currently a resident physician in my institution. He will make an oral presentation for another abstract in the CNS section today. Very enthusiastic, isn’t he? #ASTRO25